Bioventus Inc.BVSNASDAQ
Loading
EBITDA as a percentage of revenue
5Y CAGR
+1.9%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 18.58% | +171.6% |
| 2024 | 6.84% | +251.9% |
| 2023 | -4.50% | +81.0% |
| 2022 | -23.75% | -325.0% |
| 2021 | 10.55% | -37.6% |
| 2020 | 16.91% | -6.6% |
| 2019 | 18.11% | +6.0% |
| 2018 | 17.08% | -16.6% |
| 2017 | 20.49% | +27.7% |
| 2016 | 16.05% | - |